Stroke and Cerebrovascular Diseases Registry

计划入组 4,594 人 · 首次发布于 2017 年 9 月 13 日

Cerebrovascular Disease: Quality of Life (CODE: QoL)

计划入组 680 人 · 首次发布于 2024 年 6 月 5 日

Multi-Modality Imaging Standard Cohort Of Cerebrovascular Disease

计划入组 800 人 · 首次发布于 2025 年 4 月 13 日

PDE1A inhibitors (cerebrovascular disease)

Clopidogrel(Duoplavin, Plavix, Zyllt, Clopidogrel BGR (previously Zylagren), Clopidogrel TAD, Clopidogrel ratiopharm, Clopidogrel Zentiva (previously Clopidogrel Winthrop), Clopidogrel Krka, Clopidogrel Krka d.d. (previously Zopya), Clopidogrel Teva (hydrogen sulphate), Clopidogrel HCS, Iscover, Grepid, Clopidogrel Taw Pharma (previously Clopidogrel Mylan), Clopidogrel Viatris (previously Clopidogrel Taw Pharma), Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover), DuoPlavin)

C₁₆H₁₆ClNO₂S · Rx

Vinpocetine

C₂₂H₂₆N₂O₂ · Rx

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

CURE RARE DISEASE, INC.

United States

Remdesivir Shows Modest Reduction in Long COVID Risk Among Hospitalized Patients

South Korea Launches National Biobank of Normal Tissues from Deceased Donors to Advance Precision Medicine

UC Davis Researchers Awarded $3.3 Million NIH Grant to Study Cultural Differences in Subjective Cognitive Decline